| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga’s Edge Stock Rankings, showing remarkable strength and fervor over the past week.
In Benzinga’s Edge Rankings, the Momentum score basically indicates the strength of a stock relative to all other stocks ranked. It considers price movements and volatility across multiple time frames, before ranking them individually as a percentile against others.
Over the past week, these two health-tech stocks have seen significant improvements in their respective momentum scores, and here's why?
Swiss medtech company, Sophia Genetics SA (NASDAQ:SOPH), has seen its Benzinga Momentum score surge over the past week, rising from 32.45 to 81.80.
This comes following the stock’s 30% surge over the past month, after the company expanded its collaboration with AstraZeneca PLC (NASDAQ:AZN) to jointly develop an AI-powered next-generation sequencing solution targeting breast and prostate cancer.
The stock scores high on Momentum in Benzinga’s Edge Stock Rankings, with a favorable price trend in the short, medium and long terms. Click here for deeper insights into the stock, its peers and competitors.
New York-headquartered DarioHealth Corp. (NASDAQ:DRIO) makes personalized health management solutions, particularly for those suffering from chronic conditions.
The stock’s Momentum score surged from 7.69 to 59.45 within the span of a week, in line with the stock that has soared over 83% within the past month. This rally has been driven by the company’s announcement that it had formed a committee to explore a potential sale, merger or business combination.
According to Benzinga’s Edge Stock Rankings, the stock does fairly well on Momentum, with a favorable price trend in the short, medium and long terms. Click here for deeper insights into the stock, its peers and competitors.
Read More:
Photo courtesy: Korot Yurii on Shutterstock.com
